Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile
RAMAT GAN, Israel, March 14, 2024 /PRNewswire/ — Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use